During the past decade, Associated Retina Consultants, Ltd. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Associated Retina Consultants, Ltd." are "Age-related Macular Degeneration" (1 trials), "Macular Edema" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Associated Retina Consultants, Ltd." in a lesser frequency.

Most popular intervention types in "Associated Retina Consultants, Ltd." are "Combination Product" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "IVT aflibercept" (1 trials), "Subcutaneos placebo through the elamipretide delivery system" (1 trials), "Subcutaneous elamipretide through the elamipretide delivery system" (1 trials), "suprachoroidal CLS-TA" (1 trials) and "suprachoroidal sham" (1 trials). Other intervention names were less common.

The vast majority of trials in "Associated Retina Consultants, Ltd." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Associated Retina Consultants, Ltd.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Associated Retina Consultants, Ltd., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Associated Retina Consultants, Ltd., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".